Labcorp
Labcorp, officially known as Laboratory Corporation of America Holdings, is a leading global life sciences company headquartered in the United States. Founded in 1971, Labcorp has established itself as a key player in the diagnostics and drug development sectors, with a strong presence across North America and Europe. The company offers a comprehensive range of laboratory services, including clinical laboratory testing, drug development, and genomic testing. Labcorp's commitment to innovation and quality sets it apart, providing healthcare professionals with critical insights to improve patient outcomes. Recognised for its extensive test menu and advanced technologies, Labcorp has achieved significant milestones, including the introduction of pioneering diagnostic solutions. With a robust market position, Labcorp continues to drive advancements in healthcare, making it a trusted partner for patients and providers alike.
DitchCarbon Score
How does Labcorp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Labcorp's score of 38 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Labcorp's reported carbon emissions
In 2023, Labcorp reported total carbon emissions of approximately 331,967,000 kg CO2e. This figure includes 182,265,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 149,702,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, Labcorp's Scope 3 emissions totalled about 1,050,378,000 kg CO2e, encompassing emissions from the entire value chain, including purchased goods and services, upstream and downstream transportation, and fuel-related activities. Labcorp has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the base year. Furthermore, the company is committed to a 25% reduction in absolute Scope 3 emissions from key areas such as purchased goods and services, upstream transportation, and downstream transportation within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. Overall, Labcorp's proactive approach to managing its carbon footprint reflects its commitment to sustainability and climate responsibility within the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 173,797,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 175,982,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 909,611,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Labcorp is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
